1. Home
  2. AQST vs BNY Comparison

AQST vs BNY Comparison

Compare AQST & BNY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AQST
  • BNY
  • Stock Information
  • Founded
  • AQST 2004
  • BNY 2001
  • Country
  • AQST United States
  • BNY United States
  • Employees
  • AQST N/A
  • BNY N/A
  • Industry
  • AQST Biotechnology: Pharmaceutical Preparations
  • BNY Trusts Except Educational Religious and Charitable
  • Sector
  • AQST Health Care
  • BNY Finance
  • Exchange
  • AQST Nasdaq
  • BNY Nasdaq
  • Market Cap
  • AQST 272.9M
  • BNY 232.5M
  • IPO Year
  • AQST 2018
  • BNY N/A
  • Fundamental
  • Price
  • AQST $3.40
  • BNY $9.74
  • Analyst Decision
  • AQST Strong Buy
  • BNY
  • Analyst Count
  • AQST 6
  • BNY 0
  • Target Price
  • AQST $10.67
  • BNY N/A
  • AVG Volume (30 Days)
  • AQST 1.6M
  • BNY 52.7K
  • Earning Date
  • AQST 08-05-2025
  • BNY 01-01-0001
  • Dividend Yield
  • AQST N/A
  • BNY 3.93%
  • EPS Growth
  • AQST N/A
  • BNY N/A
  • EPS
  • AQST N/A
  • BNY N/A
  • Revenue
  • AQST $54,228,000.00
  • BNY N/A
  • Revenue This Year
  • AQST N/A
  • BNY N/A
  • Revenue Next Year
  • AQST $45.71
  • BNY N/A
  • P/E Ratio
  • AQST N/A
  • BNY N/A
  • Revenue Growth
  • AQST 5.29
  • BNY N/A
  • 52 Week Low
  • AQST $2.12
  • BNY $8.60
  • 52 Week High
  • AQST $5.80
  • BNY $10.80
  • Technical
  • Relative Strength Index (RSI)
  • AQST 58.21
  • BNY 56.39
  • Support Level
  • AQST $3.13
  • BNY $9.59
  • Resistance Level
  • AQST $3.33
  • BNY $9.69
  • Average True Range (ATR)
  • AQST 0.21
  • BNY 0.08
  • MACD
  • AQST -0.03
  • BNY 0.02
  • Stochastic Oscillator
  • AQST 46.94
  • BNY 94.74

About AQST Aquestive Therapeutics Inc.

Aquestive Therapeutics Inc is a specialty pharmaceutical company engaged in developing and commercializing differentiated products to meet medical needs. Its later-stage product pipeline focuses on the treatment of diseases of the Central Nervous System (CNS), and an earlier-stage pipeline for the treatment of severe allergic reactions, including anaphylaxis. Its commercial product portfolio includes Suboxone, Emylif, Ondif and Sympazan. The product pipeline includes Libervant Buccal Film, AQST-108. The majority of its revenue comes from the United States.

About BNY BlackRock New York Municipal Income Trust

Blackrock NY Municipal Income Tr investment objective is to provide shareholders with as high a level of current income exempt from U.S. federal income taxes and New York State and New York City personal income taxes as is consistent with its investment policies and prudent investment management.

Share on Social Networks: